Results 91 to 100 of about 2,228 (187)

Alopecia in epidermolysis bullosa [PDF]

open access: yes, 2010
Hair abnormalities observed in epidermolysis bullosa (EB) are of variable severity and include mild hair shaft abnormalities, patchy cicatricial alopecia, cicatricial alopecia with a male pattern distribution, and alopecia universalis.
Duque-Estrada, Bruna   +2 more
core   +1 more source

Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib:A Case Report [PDF]

open access: yes, 2020
Alopecia areata (AA) is the most common immune-mediated hair loss disorder with a life-time prevalence of 2%. The pathogenesis of AA is not completely understood, but interferon gamma (INF-γ) and Janus kinases (JAK) may play a key role.
Zachariae, Claus   +2 more
core   +1 more source

ALOPECIA UNIVERSAL COMO PRESENTACIÓN INICIAL DE UN SÍNDROME POLIGLANDULAR AUTOINMUNE REPORTE DE CASO

open access: yesMedicina, 2018
Introducción: La alopecia universalis es la pérdida de pelo en todo el cuerpo por destrucción del folículo capilar. En la etiología se describen factores 1. Genéticos como alteración del cromosoma 18, haplotipos HLA DQ3, DQ7, DR4 y DR11. 2.
Liliana M. Mejía Zapata   +1 more
doaj  

Alopecia areata universalis during off-label treatment with Infliximab in a patient with Behçet disease [PDF]

open access: yes, 2010
Infliximab, a chimeric monoclonal anti-TNF-alfa agent used to treat autoimmune diseases, has shown a paradoxical side effect in the development of autoimmunity.
Fabbri P.   +4 more
core  

Growth Hormone Deficiency in a Young Patient with Alopecia Areata [PDF]

open access: yes, 2013
A young female child aged 7 years presented initially with chronic alopecia areata, which over 2 years progressed to alopecia areata ...
Bergfeld, Wilma F.
core   +1 more source

Bimatoprost in the treatment of eyelash universalis alopecia areata

open access: yesInternational Journal of Trichology, 2010
To evaluate topical bimatoprost for eyelash growth in patients with alopecia areata (AA).A 1-year retrospective study, bilateral eyelash alopecia.Forty-one subjects with AA universalis without ocular disease applied 0.03% bimatoprost to the eyelid margin once a day over the course of 1 year.Thirty-seven subjects completed the study, one patient was ...
Vila, Teresa Ojeda   +1 more
openaire   +3 more sources

Hepatitis C Treatment and Alopecia Totalis [PDF]

open access: yes, 2013
Peg-interferon alpha-2a and 2b and ribavirin have become the mainstays of chronic hepatitis C treatment. Although various cutaneous side effects have been reported, alopecia areata in its various forms have rare reports and has not been well categorized.
Goh, Carolyn
core   +1 more source

Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older

open access: yesActas Dermo-Sifiliográficas
Alopecia areata (AA) is a dermatological disease of immune origin characterized by partial or total hair loss of the scalp (alopecia totalis) or the whole body (alopecia universalis).
S. Vañó-Galván   +5 more
doaj   +1 more source

Interleukin-1 Receptor Antagonist Allele 2 and Familial Alopecia Areata [PDF]

open access: yes, 2002
Alopecia areata affects 1%-2% of the population and is hypothesized to be an autoimmune, organ specific T-cell mediated reaction directed against the human hair follicle.
Barahamani, Nazila   +9 more
core   +1 more source

Molecular signatures define alopecia areata subtypes and transcriptional biomarkers

open access: yesEBioMedicine, 2016
Alopecia areata (AA) is an autoimmune disease typified by nonscarring hair loss with a variable clinical course. In this study, we conducted whole genome gene expression analysis of 96 human scalp skin biopsy specimens from AA or normal control subjects.
Ali Jabbari   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy